Regulatory Perspectives in Pharmacometric Models of Osteoporosis

Journal of Clinical Pharmacology
Kumpal MadrasiLi Li

Abstract

Osteoporosis is a disorder of the bones in which they are weakened to the extent that they become more prone to fracture. There are various forms of osteoporosis: some of them are induced by drugs, and others occur as a chronic progressive disorder as an individual gets older. As the median age of the population rises across the world, the chronic form of the bone disease is drawing attention as an important worldwide health issue. Developing new treatments for osteoporosis and comparing them with existing treatments are complicated processes due to current acceptance by regulatory authorities of bone mineral density (BMD) and fracture risk as clinical end points, which require clinical trials to be large, prolonged, and expensive to determine clinically significant impacts in BMD and fracture risk. Moreover, changes in BMD and fracture risk are not always correlated, with some clinical trials showing BMD improvement without a reduction in fractures. More recently, bone turnover markers specific to bone formation and resorption have been recognized that reflect bone physiology at a cellular level. These bone turnover markers change faster than BMD and fracture risk, and mathematically linking the biomarkers via a computational ...Continue Reading

References

Dec 8, 1978·Calcified Tissue Research·F Melsen, L Mosekilde
Jan 1, 1992·Annual Review of Pharmacology and Toxicology·L B Sheiner, T M Ludden
Mar 1, 1990·Annals of Internal Medicine·B P Lukert, L G Raisz
May 21, 1986·Journal of Theoretical Biology·L A SegelB E Knox
Jan 1, 1996·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·J M PouillèsC Ribot
Jan 1, 1997·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
Jul 21, 1998·Endocrinology and Metabolism Clinics of North America·P Garnero, P D Delmas
Dec 5, 1998·Annals of Clinical Biochemistry·P A KydA Fairney
Feb 2, 1999·Journal of Evaluation in Clinical Practice·B Hurwitz
Aug 24, 1999·Annals of Clinical Biochemistry·P A KydA Fairney
Nov 5, 1999·Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry·P D Ross
Feb 1, 2000·Trends in Endocrinology and Metabolism : TEM·J A KanisC Cooper
Feb 29, 2000·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·H K GenantN Khaltaev
Jun 3, 2000·Annual Review of Pharmacology and Toxicology·L B Sheiner, J L Steimer
Aug 10, 2000·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·P GarneroP D Delmas
Oct 19, 2000·Baillière's Best Practice & Research. Clinical Endocrinology & Metabolism·C J Rosen
Dec 29, 2000·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·H LuukinenH K Väänänen
Jan 10, 2001·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·D HaguenauerG Wells
Jan 10, 2001·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·S StörkW Rambeck
Jan 12, 2001·Physiological Reviews·J E Compston
Jul 12, 2001·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·G KhastgirA J Bailey
Jul 23, 2002·Journal of the American Geriatrics Society·Elizabeth A EastwoodAlbert L Siu
Sep 6, 2002·The Journal of Clinical Endocrinology and Metabolism·J F RaposoH G Ferreira
Oct 5, 2002·The Journal of Clinical Endocrinology and Metabolism·A RogersR Eastell
Jan 10, 2003·Journal of Cellular Biochemistry·B Lawrence Riggs
Feb 6, 2003·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Kathryn L ShultzWesley G Beamer
Jun 24, 2003·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·J A KanisF Caulin
Aug 9, 2003·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·C J HernandezD R Carter
Sep 11, 2003·Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons·Robert E Marx
Sep 25, 2003·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·Mary L Bouxsein
Sep 26, 2003·Calcified Tissue International·J C van der LindenH Weinans
Nov 11, 2003·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Katie L StoneUNKNOWN Osteoporotic Fractures Research Group
Jul 6, 2004·Journal of Theoretical Biology·Vincent LemaireLarry J Suva
Apr 21, 2005·The Journal of Clinical Endocrinology and Metabolism·Harald DobnigErik F Eriksen

❮ Previous
Next ❯

Citations

Jan 29, 2019·British Journal of Clinical Pharmacology·Matthew M Riggs, Serge Cremers
Dec 5, 2020·Journal of Clinical Pharmacology·Yi Ting Kayla LienStephan Schmidt

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.